Pharmana Wider View Vol.2 – Cardiovascular Disease

Pharmana Wider View Vol.2 – Cardiovascular Disease 150 150 mana

PHARMANA WIDER VIEW - August 2019 Vol2

Cardiovascular disease (CVD), or heart disease, is an umbrella term that includes all conditions affecting the heart.
By 2020, 50 percent of global health care expenditures – about $4 trillion – will be spent on three leading causes of death: cardiovascular diseases, cancer and respiratory diseases.
According to WHO report in 2010, the age standardized rates of CVD and diabetes-related deaths in Iran were 421 per 100,000 in men and 348 per 100,000 in women.

Read Pharmana Wider View: Vol2.Cardiovascular Disease to get insights

Topics in this newsletter:

  • In the Heart of Cardiovascular Disease
  • Suggested steps for MedTech in CVD
  • Evercore; Investment Banking Advisory
  • Iran National Innovation Fund
  • The Research and Technology Fund of Iran University of Science and Technology
  • Tehran and NYSE Stock Index
  • Mergers and Acquisitions (M&A) Term
  • Advanced in Science and Technology
  • Takeda – Shire Blockbuster Deal & Risks
  • Expanding Access to Low Cost, High-Quality Tertiary Care
  • Independence Against Sanctions by Innovation
  • American Depositary Share (ADS) Term
  • What is Respite Care?

Download WIDER VIEW Vol.2 - August 2019

پشتیبانی مانا
چگونه می توانیم به شما کمک کنیم؟
گروه مشاوره مانا
راهکاری هوشمندانه